Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Pain After Thoracoscopic Lung Surgery - the Effect of Intercostal Nerve Blockades With Standard Bupivacaine and Liposomal Bupivacaine - a Randomised Controlled Feasibility Trial

NCT05038007 is registered in ClinicalTrials.gov with Jannie Bisgaard Stæhr as lead sponsor.

NCT NCT05038007
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05038007 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Pain After Thoracoscopic Lung Surgery - the Effect of Intercostal Nerve Blockades With Standard Bupivacaine and Liposomal Bupivacaine - a Randomised Controlled Feasibility Trial
Lead sponsor
Jannie Bisgaard Stæhr
Phase
Phase 2
Overall status
Unknown status
Start date
September 15, 2021
Completion date
May 31, 2022
Enrollment
50 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

anesthesia, local, blockades neuromuscular, lung cancer, postoperative pain, video assisted thoracoscopic surgery